Biological E Gets CDSCO Panel Nod to study safety of XBB 1.5-RBD Subunit Covid-19 Vaccine in 5-80 years old Dr. Divya Colin28 Dec 2023 6:00 PM ISTNew Delhi: The drug major Biological E has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
WHO Adds R21/Matrix-M Malaria Vaccine to Prequalified List Jacinthlyn Sylvia24 Dec 2023 8:45 PM ISTMalaria inflicts a disproportionate burden on children in the African Region, taking up nearly half a million lives annually. Global statistics from...
WHO adds SII-Oxford University Malaria vaccine to its list of prequalified vaccines Ruchika Sharma23 Dec 2023 3:00 PM ISTThe prequalification of the world's second malaria vaccine, developed by Oxford University and manufactured by Serum Institute of India, is poised to...
USFDA grants priority review to Merck investigational 21-valent Pneumococcal Conjugate Vaccine specifically designed to protect adults Ruchika Sharma21 Dec 2023 3:47 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
Maternal influenza vaccination during pregnancy may protect infant in first few months of life: JAMA Dr Riya Dave19 Dec 2023 11:30 PM ISTA recent study exploring the impact of maternal influenza vaccination during pregnancy has shown promising outcomes in reducing influenza-related...
Melanoma vaccine could be available by 2025: Moderna CEO Ruchika Sharma17 Dec 2023 1:00 PM ISTWashington: Moderna CEO Stephane Bancel told AFP his company's experimental vaccine against melanoma could be available in as little as two...
Japan accepts GSK Arexvy regulatory application to prevent RSV disease in adults aged 50-59 at increased risk Ruchika Sharma14 Dec 2023 10:00 AM ISTLondon: GSK plc has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has accepted for review a regulatory application to extend...
AstraZeneca to acquire vaccine developer Icosavax for up to USD 1.1 billion Ruchika Sharma12 Dec 2023 3:30 PM ISTCambridge: AstraZeneca has entered into a definitive agreement to acquire Icosavax, Inc., a US-based clinical-stage biopharmaceutical company...
Pfizer, Valneva conclude recruitment for Phase 3 trial for Lyme Disease Vaccine candidate VLA15 Ruchika Sharma8 Dec 2023 2:30 PM ISTNew York: Pfizer Inc. and Valneva SE have announced that they have completed recruitment for the Phase 3 trial Vaccine Against Lyme for Outdoor...
Complications from flu largely preventable with annual flu vaccine Dr. Kamal Kant Kohli5 Dec 2023 11:00 PM ISTDuring National Influenza Vaccination Week (December 4-8, 2023), leading public health organizations are encouraging everyone to get a flu shot if...
Maternal COVID-19 Vaccination Lowers risk of infection by omicron varient among infants: JAMA Jacinthlyn Sylvia4 Dec 2023 5:00 PM ISTIn a recent population-based cohort study Orlanda Goh and colleagues unveiled crucial insights into the impact of maternal mRNA vaccination on the...
Merck 21-valent Pneumococcal Conjugate Vaccine demonstrates superior immunogenicity for 10 of 11 Unique Serotypes compared to PCV20 in adults 50 years of age and older Ruchika Sharma30 Nov 2023 1:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced results from STRIDE-3, a Phase 3 trial evaluating V116, the...
